Prognostic nutritional index predicts the prognostic impact of avelumab maintenance therapy in patients with advanced urothelial carcinoma: results from the Chu-shikoku Japan Urological Consortium
Pretreatment low PNI was associated with poor survival outcome in avelumab maintenance therapy. This finding provides support for the potential role of PNI as a prognostic factor of avelumab maintenance therapy.
Authors
- Kohei Ogawa (ORCID: https://orcid.org/0000-0002-5672-6308)
- Yoichiro Tohi (ORCID: https://orcid.org/0000-0003-3884-8915)
- Satoshi Katayama (ORCID: https://orcid.org/0000-0002-8377-2457)
- Ryu Shigehisa
- Junya Furukawa
- Ryotaro Tomida (ORCID: https://orcid.org/0000-0002-2518-0197)
- Kenichi Nishimura
- Koichiro Wada
- Shinkuro Yamamoto (ORCID: https://orcid.org/0000-0002-3620-7666)
- Koji Shiraishi
- Atsushi Takamoto
- Hideo Fukuhara
- Ryutaro Shimizu
- Kensuke Bekku
- Noriyoshi Miura
- Shuichi Morizane
- Keita Kobayashi
- Shingo Nishimura
- Keiji Inoue
- Takuma Kato
Institutions
- Okayama University (JP)
- Shimane University (JP)
- Yamaguchi University (JP)
- Kagawa University (JP)
- Kochi Medical School Hospital (JP)
- Fukuyama City Hospital (JP)
- Ehime University (JP)
- Tottori University (JP)
- Kōchi University (JP)
- Tokushima University (JP)
Publication Details
- Journal
- Japanese Journal of Clinical Oncology
- Published
- 2025-12-20
- DOI
- https://doi.org/10.1093/jjco/hyaf208
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00